Complex chronic comorbidities of COPD
LM Fabbri, F Luppi, B Beghé… - European Respiratory …, 2008 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation
associated with an abnormal pulmonary and systemic inflammatory response of the lungs to
cigarette smoke. The systemic inflammation induced by smoking may also cause chronic
heart failure, metabolic syndrome and other chronic diseases, which may contribute to the
clinical manifestations and natural history of COPD. Thus COPD can no longer be
considered a disease only of the lungs, as it is often associated with a wide variety of …
associated with an abnormal pulmonary and systemic inflammatory response of the lungs to
cigarette smoke. The systemic inflammation induced by smoking may also cause chronic
heart failure, metabolic syndrome and other chronic diseases, which may contribute to the
clinical manifestations and natural history of COPD. Thus COPD can no longer be
considered a disease only of the lungs, as it is often associated with a wide variety of …
Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation associated with an abnormal pulmonary and systemic inflammatory response of the lungs to cigarette smoke.
The systemic inflammation induced by smoking may also cause chronic heart failure, metabolic syndrome and other chronic diseases, which may contribute to the clinical manifestations and natural history of COPD. Thus COPD can no longer be considered a disease only of the lungs, as it is often associated with a wide variety of systemic consequences.
A better understanding of the origin and consequences of systemic inflammation, and of potential therapies, will most likely lead to better care of patients with COPD. Medical textbooks and clinical guidelines still largely ignore the fact that COPD seldom occurs in isolation.
As the diagnosis and assessment of severity of COPD may be greatly affected by the presence of comorbid conditions, the current authors believe that lung function measurement, noninvasive assessment of cardiovascular and metabolic functions, and circulating inflammatory markers (e.g. C-reactive protein) might help to better characterise these patients. Similarly, preventive and therapeutic interventions should address the patient in their complexity.
European Respiratory Society以上显示的是最相近的搜索结果。 查看全部搜索结果